dehydrogenase(MCAD) deficiencyin dried bloodspots by a polymerase chain reaction (PCR) assay detecting a point-mutation We evaluated a novel system designed for rapid, pointof-care measurement of sodium, potassium, chloride, urea nitrogen, glucose, and hematocrit. Important criteria for the acceptance of point-of-care systems are that they allow operators without technical training to perform assays easily and achieve accuracy and precision of measurement equivalent to that obtainable in the clinical laboratory, or for specific clinical purposes. To assess the adherence to these criteria, it is important to evaluate such devices in settings where operation at the point of care by nontechnical operators can be contrasted with state-of-the-art laboratory performance, and to assess the likely impact on care of patients.
time. Most of these devices are dedicated to glucose analysis (4), but increasing attention has been paid in recent years to the development of bedside systems capable of a wider spectrum of analyses. Improvements in biosensor technology have permitted the production of various devices that detect and quantify electrolytes and other analytes (5, 6).
Important criteria for the acceptance of point-of-care systems are that they allow operators without technical training to perform assays easily and achieve accuracy and precision of measurement equivalent to that obtainable in the clinical laboratory, or for specific clinical purposes. To assess the adherence to these criteria, it is important to evaluate such devices in settings where operation at the point of care by nontechnical operators can be contrasted with state-of-the-art laboratory performance, and to assess the likely impact on care of patients.
A novel system, the i-STAT Portable Clinical Ana-
lyzer (PCA; i-STAT Corp., Princeton, NJ) is a hand-held
analyzer that performs simultaneous assays of whole blood in <2 mm for sodium, potassium, chloride, glucose, urea nitrogen, and hematocrit. In thus study we evaluated the i-STAT PCA for performance in the clinical laboratory and in the emergency department of a large general hospital.
MaterIals and Methods System
The i-STAT System is composed of two main parts, the portable hand-held analyzer and disposable cartridges. The analyzer (Figure 1 ) measures 20 X 6.5 X Fig. 2 (Figure 2 ), 2.7 x 4.5 cm, contain calibrant solution, a sample-handling system, conductivity pads that make electrical contact with the analyzer, and a series of biosensors. The biosensors are thin-film electrodes mmcrofabricated on silicon chips. Part of the electrode sequence is illustrated in Figure 3 . Sodium, potassium, and chloride are measured by direct ion-selective electrode potentiometry.
Urea is hydrolyzed to ammomum in a reaction catalyzed by urease, and the ammonium ions are then measured by ion-selective electrode. Glucose is measured amperometrically via the product (H202) of the glucose oxidase reaction. Hematocrit is determined by conductivity.
Operation
The whole-blood specimen (-65 L) is introduced into the cartridge by using a capillary tube or syringe. The cartridge is then inserted into the analyzer, which activates the analyzer. At the appropriate prompt, the patient and operator identification numbers can be entered by using the numeric keypad. Each cartridge contains a sealed foil pack of calibrant solution. In the first part of the testing cycle, the pack is ruptured and the calibrant solution is automatically transported over the biosensors. The signals produced by the biosensors in response to the calibrant solution are conducted from contact pads on the cartridge to the analyzer, where they are processed and stored. When thus process is completed, the analyzer automatically displaces the calibrant and moves the sample over the sensors. The concentration of each analyte is determined by comparing the sensors'response to the sample with that of the calibrant. One cartridge is used for each specimen and then is discarded. The specimen is contained within the cartridge and does not come in contact with the analyzer at any time.
The system is designed for the analyses of venous or capilliary specimens, but we analyzed only venous specimens in thus study.
EvaluationStudies
The and hematology (tubes containing potassium EDTA) tests as part of the patients' routine care. For thus study, we drew an additional specimen into a tube containing lithium heparin; thus sample was analyzed in duplicate in the emergency department with the i-STAT PCA. The specimens were then transported to the stat laboratory via pneumatic tube. In the stat laboratory, the hepariized whole blood was analyzed again, in duplicate, with the PCA by trained laboratory personnel. Hematocrit was also measured on the Coulter ST (Coulter Electronics, Miami, FL). The heparinized plasma was analyzed by the established laboratory methods in our institution-Kodak Ektachem 700 (Eastman Kodak Co., Rochester, NY) (9). The data from the method comparison study were evaluated by use of Deming regression analysis (10).
Results
Imprecision. Table 1 summarizes the total imprecision obtained from the i-STAT PCA in the stat laboratory and the emergency department. The data for urea nitrogen are divided into two sets, reflecting the change in the cartridge manufacturing process during the study. Data were collected for urea nitrogen with the new cartridges for 16 days.
Data for imprecision of hematocrit determinations are not presented because the control material used was aqueous, not blood-based. However, an estimate of imprecision for thus analyte is deduced from assay of duplicate patient samples (see S,,1,,data in Table 2 ).
In comparison, the imprecision data (CV %) for the five chemistry analytes determined by the Kodak Ek- Unitsaremmol/L exceptforhematocrits, which arepercent, expressed as a numberfraction. tachem 700 for comparable analyte concentrations over a long period (>1 year) are as follows: sodium and chloride 1.0%, potassium 1.5%, glucose 2.0%, and urea nitrogen s2.5%.
Reliability.
In the stat laboratory, 1073 cartridges from 10 different lots were used. We noted 13 (1.2%) occasions on which no results were provided. [Note:
Stars appear on the display panel instead of results whenever the internal monitoring systems detect failure to achieve correct fluid flow or failure to complete satisfactory analyte detection and quantification.] The failure to present a result usually indicates the operation of the "fail-safe" mechanisms in the PCA. In this study, nine system failures involved multiple tests, and four were for single tests (two for glucose and two for chloride).
In the emergency department, 298 cartridges were used from six different lots. Thirteen Methods (X)a the results from the PCA in the emergency department and the PCA in the stat laboratory. Table 3 compares results from the analysis of whole blood by the PCA in the stat laboratory with those for plasma by the Kodak Ektachem 700. For some analytes, the average differences between the PCA and the comparison methods varied with concentration. Therefore, to clearly describe the system differences (Table 4) , we distributed the data into concentration groups. We also show a difference plot between the PCA and the Kodak Ektachem 700 (Figure 4 ) results for chloride. This format of data presentation is particularly valuable when the range of analyte concentration is limited, illustrating a more nearly accurate assessment of the bias between the methods.
Discussion
The Table 4 shows that the performance of the PCA for glucose in comparison with the Ektachem assay was problematic only at concentrations >11.1 mmol/L (>2.00 g/L). Comparison of the two PCA settings ( Table 3 were influenced by the narrow range of concentrations for this constituent (10). The system difference analysis (Table 4) showed that the average difference was only 1.91 mmolJL, and the difference plot (Figure 4) Table 4 ). The differences noted were probably due to the different calibration procedures used on the two systems, the effect of different anticoagulants on impedance measurements, and the inherent differences in the technologies.
Institutional demands on clinical laboratory directors invariably concentrate on questions about the expense of providing service, and assurance that clinical and legislated requirements of quality are met (11). At the same time, the clinician is concerned primarily with questions relating to turnaround time, appropriate test combinations, and comprehensible data presentation. Suppliesfor this evaluation were provided by the i-STAT Corporation.
